APA (7th ed.) Citation

J, S., MJ, A., J, M., F, B., J, M., J, M., . . . A, S. (2024). Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics, 16(12), . https://doi.org/10.3390/pharmaceutics16121585

Chicago Style (17th ed.) Citation

J, Salazar, et al. "Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol." Pharmaceutics 16, no. 12 (2024). https://doi.org/10.3390/pharmaceutics16121585.

MLA (9th ed.) Citation

J, Salazar, et al. "Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol." Pharmaceutics, vol. 16, no. 12, 2024, https://doi.org/10.3390/pharmaceutics16121585.